139 related articles for article (PubMed ID: 34131532)
41. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.
Darling TN; Skarulis MC; Steinberg SM; Marx SJ; Spiegel AM; Turner M
Arch Dermatol; 1997 Jul; 133(7):853-7. PubMed ID: 9236523
[TBL] [Abstract][Full Text] [Related]
42. Phakomatoses.
Becker B; Strowd RE
Dermatol Clin; 2019 Oct; 37(4):583-606. PubMed ID: 31466597
[TBL] [Abstract][Full Text] [Related]
43. Laser treatment of angiofibromas in tuberous sclerosis.
Pignatti M; Spaggiari A; Sala P; Loschi P; Fiumana E; Faggioli R
Minerva Pediatr; 2014 Dec; 66(6):585-6. PubMed ID: 25336102
[TBL] [Abstract][Full Text] [Related]
44. A subtle case of tuberous sclerosis complex.
Nakano H; Otsuka A; Kinoshita M
Epilepsy Behav Case Rep; 2015; 4():88-90. PubMed ID: 26543814
[TBL] [Abstract][Full Text] [Related]
45. Tuberous sclerosis and cutaneous stigmata: ever-expanding spectrum.
Madaan P; Saini L; Sankhyan N; De D; Kesavan S; Mukherjee S; Vaiphei K; Ahuja CK
Arch Dis Child; 2020 Aug; 105(8):797. PubMed ID: 31072875
[No Abstract] [Full Text] [Related]
46. Types I and III collagens and the activities of prolyl hydroxylase and galactosylhydroxylysyl glucosyltransferase in skin lesions of tuberous sclerosis.
Oikarinen A; Palatsi R; Linna SL; Peltonen L
Br J Dermatol; 1982 Dec; 107(6):659-64. PubMed ID: 6293527
[TBL] [Abstract][Full Text] [Related]
47. Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.
Wataya-Kaneda M; Tanaka M; Yang L; Yang F; Tsuruta D; Nakamura A; Matsumoto S; Hamasaki T; Tanemura A; Katayama I
JAMA Dermatol; 2015 Jul; 151(7):722-30. PubMed ID: 25692384
[TBL] [Abstract][Full Text] [Related]
48. Tuberous sclerosis.
Kwiatkowski DJ; Short MP
Arch Dermatol; 1994 Mar; 130(3):348-54. PubMed ID: 8129414
[TBL] [Abstract][Full Text] [Related]
49. Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.
Bongiorno MA; Nathan N; Oyerinde O; Wang JA; Lee CR; Brown GT; Moss J; Darling TN
JAMA Dermatol; 2017 Jul; 153(7):660-665. PubMed ID: 28445558
[TBL] [Abstract][Full Text] [Related]
50. Tuberous sclerosis with portal vein thrombosis, protein C and S deficiency.
Vasudevan B; Sawhney MP; Radhakrishnan S; Shilpa G
Indian J Dermatol Venereol Leprol; 2007; 73(6):412-4. PubMed ID: 18032862
[TBL] [Abstract][Full Text] [Related]
51. Tuberous Sclerosis with Severe Cutaneous Manifestation and Multiples Facial Angiofibromas.
Garcia NG; de Carli ML; Oliveira DT; Soares CT; Ribeiro Júnior NV; Sperandio FF; Hanemann JA
Head Neck Pathol; 2016 Dec; 10(4):542-546. PubMed ID: 27140177
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous Manifestations of Tuberous Sclerosis.
Bakić M; Ratković M; Gledović B; Vujović B; Radunović D; Babić V; Prelević V
Acta Dermatovenerol Croat; 2018 Apr; 26(1):73-74. PubMed ID: 29782307
[TBL] [Abstract][Full Text] [Related]
53. Fibrous Cephalic Plaque in Tuberous Sclerosis Complex: Treatment With 0.2% Rapamycin.
Giacaman A; Martín-Santiago A
Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):e13. PubMed ID: 30846165
[No Abstract] [Full Text] [Related]
54. [Partial seizures in a newborn with tuberous sclerosis].
Falero Gallego MP; Verdú Pérez A; López Lozano Y; Ureta Huertos A
An Esp Pediatr; 2000 Feb; 52(2):164-7. PubMed ID: 11003883
[TBL] [Abstract][Full Text] [Related]
55. Cephalic Fibrous Plaque in Tuberous Sclerosis.
Neema S; Mukherjee S; Battula S
Indian Pediatr; 2023 Apr; 60(4):327. PubMed ID: 37002852
[No Abstract] [Full Text] [Related]
56. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
57. Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial.
Wataya-Kaneda M; Nagai H; Ohno Y; Yokozeki H; Fujita Y; Niizeki H; Yoshida K; Ogai M; Yoshida Y; Asahina A; Fukai K; Tateishi C; Hamada I; Takahata T; Shimizu K; Shimasaki S; Murota H
Dermatol Ther (Heidelb); 2020 Aug; 10(4):635-650. PubMed ID: 32385845
[TBL] [Abstract][Full Text] [Related]
58. Zosteriform Collagen Nevus in an Infant.
Aksu Çerman A; Aktaş E; Kıvanç Altunay IK; Demirkesen C
Acta Dermatovenerol Croat; 2016 Jun; 24(2):148-9. PubMed ID: 27477177
[TBL] [Abstract][Full Text] [Related]
59. Peripapillar retinal hamartoma associated with tuberous sclerosis. Case report.
Hernández Pardines F; Núñez Márquez S; Fernández Montalvo L; Serra Verdú MC; Juárez Marroquí A
Arch Soc Esp Oftalmol (Engl Ed); 2018 Mar; 93(3):151-154. PubMed ID: 28559053
[TBL] [Abstract][Full Text] [Related]
60. A different approach for identifying hypomelanotic macules in tuberous sclerosis complex.
Gualandri L; Boccardi D; Menni S
G Ital Dermatol Venereol; 2015 Oct; 150(5):501-3. PubMed ID: 26333551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
